MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus.

CNS Neurosci Ther · 2026 · PMC12953174 · PMID 41772763

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a decreasing trendp = 0.08so close (0.05 < p ≤ 0.1)

In addition, we observed a decreasing trend of the seizure severity score in the MCC‐135 treatment group (especially in the dose group of 100 μg/kg/d, p = 0.08) (Figure 4C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.